期刊文献+

Pyroptosis is a drug target for prevention of adverse cardiac remodeling: The crosstalk between pyroptosis, apoptosis, and autophagy 被引量:2

下载PDF
导出
摘要 Acute myocardial infarction(AMI)is one of the main reasons of cardiovascular disease-related death.The introduction of percutaneous coronary intervention to clinical practice dramatically decreased the mortality rate in AMI.Adverse cardiac remodeling is a serious problem in cardiology.An increase in the effectiveness of AMI treatment and prevention of adverse cardiac remodeling is difficult to achieve without understanding the mechanisms of reperfusion cardiac injury and cardiac remodeling.Inhibition of pyroptosis prevents the development of postinfarction and pressure overload-induced cardiac remodeling,and mitigates cardiomyopathy induced by diabetes and metabolic syndrome.Therefore,it is reasonable to hypothesize that the pyroptosis inhibitors may find a role in clinical practice for treatment of AMI and prevention of cardiac remodeling,diabetes and metabolic syndrome-triggered cardiomyopathy.It was demonstrated that pyroptosis interacts closely with apoptosis and autophagy.Pyroptosis could be inhibited by nucleotide-binding oligomerization domain-like receptor with a pyrin domain 3 inhibitors,caspase-1 inhibitors,microRNA,angiotensin-converting enzyme inhibitors,angiotensinⅡreceptor blockers,and traditional Chinese herbal medicines.
出处 《The Journal of Biomedical Research》 CAS CSCD 2022年第6期375-389,共15页 生物医学研究杂志(英文版)
基金 supported by Russian Foundation of Basic Research(Grant No.21-515-53003)
  • 相关文献

参考文献4

二级参考文献35

  • 1Martinon F, Mayor A, Tschopp J. The inflammasomes: guard- ians of the body. Annu Rev Immuno12009; 27:229-265. 被引量:1
  • 2Lamkanfi M, Dixit VM. lnflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28:137- 161. 被引量:1
  • 3Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73:1907-1916. 被引量:1
  • 4Netea MG, Simon A, van de Veerdonk F, et al. IL-lbeta pro- cessing in host defense: beyond the inflammasomes. PLoS Pathog 2010; 6:e1000661. 被引量:1
  • 5Miao EA, Leaf IA, Treuting PM, et al. Caspase-l-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immuno12010; 11 : 1136-1142. 被引量:1
  • 6Lamkanfi M, Dixit VM. Mechanisms and functions of inflam- masomes. Cell 2014; 157:1013-1022. 被引量:1
  • 7Davis BK, Wen H, Ting JP. The inflammasome NLRs inimmunity, inflammation, and associated diseases. Annu Rev Immuno12011; 29:707-735. 被引量:1
  • 8Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-832. 被引量:1
  • 9Dinarello CA. Immunological and inflammatory functions of the interleukin- 1 family. Annu Rev Immunol 2009; 27:519- 550. 被引量:1
  • 10Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are in- nate immune receptors for intracellular LPS. Nature 2014; 514:187-192. 被引量:1

共引文献286

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部